Floatz logo

1,128 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Necitumumab
Non-Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer CenterP3BBB (76)
Glumetinib
Non-Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P3BBB (75)
Icotinib
Non-Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical UniversityP4BBB (74)
Veliparib
Non-Small Cell Lung Carcinoma
AbbVieP3BBB (74)
Zoledronate
Non-Small Cell Lung Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P4BBB (74)
Cediranib
Non-Small Cell Lung Carcinoma
Wake Forest University Health SciencesP2BBB (73)
plb1004
Non-Small Cell Lung Carcinoma
Beijing Pearl Biotechnology Limited Liability CompanyP3BBB (73)
Vebreltinib
Non-Small Cell Lung Carcinoma
Second Affiliated Hospital of Nanchang UniversityP3BBB (73)
Zorifertinib
Non-Small Cell Lung Carcinoma
Alpha Biopharma (Jiangsu) Co., Ltd.P2/3BBB (73)
Nogitecan
Non-Small Cell Lung Carcinoma
Fox Chase Cancer CenterP3BBB (72)
Osimertinib
Non-Small Cell Lung Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.P4BB (71)
Anvumetostat
Non-Small Cell Lung Carcinoma
AmgenP2BB (70)
ask120067
Non-Small Cell Lung Carcinoma
Jiangsu Aosaikang Pharmaceutical Co., Ltd.P3BB (70)
Cis-Diamminedichloroplatinum Ii
Non-Small Cell Lung Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.P4BB (70)
Endostatin
Non-Small Cell Lung Carcinoma
Henan Cancer HospitalP4BB (70)
Fulzerasib
Non-Small Cell Lung Carcinoma
Shandong Suncadia Medicine Co., Ltd.P3BB (70)
Glecirasib
Non-Small Cell Lung Carcinoma
Shandong Suncadia Medicine Co., Ltd.P3BB (70)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Monoclonal Jmt101 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Jmt101 ?-Chain, Dimer
Non-Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P3BB (70)
Nivestim
Non-Small Cell Lung Carcinoma
University of California, IrvineP3BB (70)
Nivolumab
Non-Small Cell Lung Carcinoma
Fred Hutchinson Cancer CenterP4BB (70)
Opnurasib
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP3BB (70)
Sigvotatug Vedotin
Non-Small Cell Lung Carcinoma
PfizerP3BB (70)
Vinorelbine Ditartrate
Non-Small Cell Lung Carcinoma
Intergroupe Francophone de Cancerologie ThoraciqueP4BB (70)
Xzp-3621
Non-Small Cell Lung Carcinoma
Xuanzhu Biopharmaceutical Co., Ltd.P3BB (70)
Zipalertinib
Non-Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer CenterP3BB (70)
Zongertinib
Non-Small Cell Lung Carcinoma
Boehringer IngelheimP3BB (70)
Alcestobart
Non-Small Cell Lung Carcinoma
BeiGeneP2BB (69)
Carboplatin
Non-Small Cell Lung Carcinoma
Jonsson Comprehensive Cancer CenterP4BB (69)
Ceralasertib
Non-Small Cell Lung Carcinoma
Mario Negri Institute for Pharmacological ResearchP3BB (69)
Cetuximab
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP3BB (69)
Dacomitinib
Non-Small Cell Lung Carcinoma
PfizerP4BB (69)
Durvalumab
Non-Small Cell Lung Carcinoma
University of ChicagoP4BB (69)
Fludeoxyglucose
Non-Small Cell Lung Carcinoma
Alliance for Clinical Trials in OncologyP3BB (69)
Gefitinib
Non-Small Cell Lung Carcinoma
Brigham and Women's HospitalP4BB (69)
Pembrolizumab
Non-Small Cell Lung Carcinoma
City of Hope Medical CenterP4BB (69)
Tislelizumab
Non-Small Cell Lung Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd.P4BB (69)
Anamorelin
Non-Small Cell Lung Carcinoma
Helsinn Healthcare SAP3BB (68)
Bl-M07D1
Non-Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3BB (68)
Dostarlimab
Non-Small Cell Lung Carcinoma
GlaxoSmithKlineP3BB (68)
Golidocitinib
Non-Small Cell Lung Carcinoma
Peking University Cancer Hospital & InstituteP2BB (68)
Lazertinib
Non-Small Cell Lung Carcinoma
Janssen Research & Development, LLCP3BB (68)
Lenvatinib
Non-Small Cell Lung Carcinoma
Sun Yat-sen UniversityP3BB (68)
Montanide Isa 51
Non-Small Cell Lung Carcinoma
Roswell Park Cancer InstituteP3BB (68)
Ono-4538
Non-Small Cell Lung Carcinoma
Ono Pharmaceutical Co., Ltd.P3BB (68)
Penpulimab
Non-Small Cell Lung Carcinoma
Yang Fan, MDP4BB (68)
Retlirafusp Alfa
Non-Small Cell Lung Carcinoma
Fudan UniversityP3BB (68)
Atezolizumab
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)P4BB (67)
Dexasone
Non-Small Cell Lung Carcinoma
Rigshospitalet, DenmarkP4BB (67)
Docetaxel
Non-Small Cell Lung Carcinoma
Genfleet Therapeutics (Shanghai) Inc.P4BB (67)
Etoposide
Non-Small Cell Lung Carcinoma
PfizerP3BB (67)
Showing 1 to 50 of 1,128 assets
PreviousPage 1 of 23Next